Curis Inc
NASDAQ:CRIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Curis Inc
NASDAQ:CRIS
|
US |
|
I
|
Immuneering Corp
NASDAQ:IMRX
|
US |
|
Flow Traders Ltd
AEX:FLOW
|
BM |
|
Oaktree Specialty Lending Corp
F:FFC0
|
US |
|
SQD.ai Strategies AG
F:IPOK
|
DE |
|
Sibanye Stillwater Ltd
F:47VS
|
ZA |
|
Vetropack Holding SA
F:VV2N
|
CH |
|
D
|
DTE Energy Co
F:DGY
|
US |
|
N
|
Nippon Steel Corp
XMUN:NPS
|
JP |
|
E
|
Everlast Minerals Ltd
ASX:EV8
|
AU |
|
FirstRand Ltd
F:FSRA
|
ZA |
|
Autoneum Holding AG
F:AN9
|
CH |
|
Y
|
Yancoal Australia Ltd
F:YA1
|
AU |
|
Information Planning Co Ltd
OTC:IPNAF
|
JP |
|
Mineralbrunnen Ueberkingen-Teinach GmbH & Co KgaA
F:MUT
|
DE |
|
Beneteau SA
F:3GD
|
FR |
|
O
|
Olin Corp
F:OLN
|
US |
|
S
|
Siemens AG
XMUN:SIE
|
DE |
Intrinsic Value
Is CRIS undervalued or overvalued?
See the intrinsic value estimate for Curis Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
CRIS looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with CRIS’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Curis Does
Curis Inc. is a biotechnology company that develops cancer drugs. Its work centers on small-molecule medicines designed to interfere with the signals that help tumor cells grow, survive, and evade the immune system. The company does not sell consumer products; it focuses on turning early-stage drug research into treatments that can be tested in patients and, if approved, sold through the healthcare system.
- Headquarters
- United States of America US
- Employees
- 22
- IPO date
- Aug 1, 2000
Revenue & Expenses Breakdown
Curis Inc
Earnings Waterfall
Curis Inc
The intrinsic value for Curis Inc (CRIS) under the Base Case is hidden USD.
Compared with the current market price of 0.39135 USD, the stock appears hidden.